mmosseveld2

Mees Mosseveld, MSc

Scientific Programmer

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Social:linkedin logo

 

 

 

 

 

 

 

 

Background

After obtaining his MSc. in Informatics at the Free University in Amsterdam, The Netherlands in 1988 he started working at the Department of Medical Informatics at the Erasmus University (became part of the Erasmus MC in 2002) and developed the decision support systems HyperCritic, BloodLink, AsthmaCritic, and CholGate. In 1995 he also got involved in building and maintaining the IPCI database.

In 2010 he joined the development team of the data transformation tool Jerboa and its successor JerboaReloaded and developed the data entry tool Chameleon.

Besides software development, he also maintains the IPCI network infrastructure and provides support to the IPCI researchers working on the IPCI database. He is also administrator of the Remote Research Environment that is used in many international projects.

Since 2017 he is also involved in OHDSI and the OMOP Common Datamodel.

 

Publications

  1. A study of PROforma, a development methodology for clinical procedures. Vollebregt A, ten Teije A, van Harmelen F, van der Lei J, Mosseveld M. Artif Intell Med. 1999 Oct;17(2):195-221.
  2. Postmarketing surveillance based on electronic patient records: the IPCI project. Vlug AE, van der Lei J, Mosseveld BM, van Wijk MA, van der Linden PD, Sturkenboom MC, van Bemmel JH. Methods Inf Med. 1999 Dec;38(4-5):339-44.
  3. Design of a decision support system for test ordering in general practice: choices and decisions to make. van Wijk M, Mosseveld M, van der Lei J. Methods Inf Med. 1999 Dec;38(4-5):355-61.
  4. Assessment of decision support for blood test ordering in primary care. a randomized trial. van Wijk MA, van der Lei J, Mosseveld M, Bohnen AM, van Bemmel JH. Ann Intern Med. 2001 Feb 20;134(4):274-81.
  5. Compliance of general practitioners with a guideline-based decision support system for ordering blood tests. van Wijk MA, van der Lei J, Mosseveld M, Bohnen AM, van Bemmel JH. Clin Chem. 2002 Jan;48(1):55-60.
  6. Feasibility of AsthmaCritic, a decision-support system for asthma and COPD which generates patient-specific feedback on routinely recorded data in general practice. Kuilboer MM, van Wijk MA, Mosseveld M, van der Does E, Ponsioen BP, de Jongste JC, Overbeek SE, van der Lei J. Fam Pract. 2002 Oct;19(5):442-7.
  7. AsthmaCritic: issues in designing a noninquisitive critiquing system for daily practice. Kuilboer MM, van Wijk MA, Mosseveld M, van der Lei J. J Am Med Inform Assoc. 2003 Sep-Oct;10(5):419-24. Epub 2003 Jun 4.
  8. Cholgate - a randomized controlled trial comparing the effect of automated and on-demand decision support on the management of cardiovascular disease factors in primary care. Van Wyk JT, Van Wijk MA, Moorman PW, Mosseveld M, Van Der Lei J. AMIA Annu Symp Proc. 2003:1040.
  9. A technical infrastructure to conduct randomized database studies facilitated by a general practice research database. Mosis G, Vlug AE, Mosseveld M, Dieleman JP, Stricker BC, van der Lei J, Sturkenboom MC. J Am Med Inform Assoc. 2005 Nov-Dec;12(6):602-7. Epub 2005 Jul 27.
  10. User requirements rating and knowledge-level of general practitioners at the start of CholGate - a lipid management decision support project. van Wyk JT, van Wijk MA, Moorman PW, Mosseveld M, van der Lei J. AMIA Annu Symp Proc. 2005:1146.
  11. Computed critiquing integrated into daily clinical practice affects physicians' behavior--a randomized clinical trial with AsthmaCritic. Kuilboer MM, van Wijk MA, Mosseveld M, van der Does E, de Jongste JC, Overbeek SE, Ponsioen B, van der Lei J. Methods Inf Med. 2006;45(4):447-54.
  12. Cost consequences of implementing an electronic decision support system for ordering laboratory tests in primary care: evidence from a controlled prospective study in the Netherlands. Poley MJ, Edelenbos KI, Mosseveld M, van Wijk MA, de Bakker DH, van der Lei J, Rutten-van Mölken MP. Clin Chem. 2007 Feb;53(2):213-9. Epub 2006 Dec 21.
  13. Electronic alerts versus on-demand decision support to improve dyslipidemia treatment: a cluster randomized controlled trial. van Wyk JT, van Wijk MA, Sturkenboom MC, Mosseveld M, Moorman PW, van der Lei J. Circulation. 2008 Jan 22;117(3):371-8. doi: 10.1161/CIRCULATIONAHA.107.697201. Epub 2008 Jan 2.
  14. Is population-oriented IT supported preventive care in general practice feasible? A database study. van Wyk JT, Mosseveld B, van der Lei J. Stud Health Technol Inform. 2010;160(Pt 1):462-5.
  15. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Wijnans L, Lecomte C, de Vries C, Weibel D, Sammon C, Hviid A, Svanström H, Mølgaard-Nielsen D, Heijbel H, Dahlström LA, Hallgren J, Sparen P, Jennum P, Mosseveld M, Schuemie M, van der Maas N, Partinen M, Romio S, Trotta F, Santuccio C, Menna A, Plazzi G, Moghadam KK, Ferro S, Lammers GJ, Overeem S, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC. Vaccine. 2013 Feb 6;31(8):1246-54. doi: 10.1016/j.vaccine.2012.12.015. Epub 2012 Dec 16.
  16. Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries. Coloma PM, Valkhoff VE, Mazzaglia G, Nielsson MS, Pedersen L, Molokhia M, Mosseveld M, Morabito P, Schuemie MJ, van der Lei J, Sturkenboom M, Trifirò G; EU-ADR Consortium. BMJ Open. 2013 Jun 20;3(6). pii: e002862. doi: 10.1136/bmjopen-2013-002862.
  17. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe. Romio S, Weibel D, Dieleman JP, Olberg HK, de Vries CS, Sammon C, Andrews N, Svanström H, Mølgaard-Nielsen D, Hviid A, Lapeyre-Mestre M, Sommet A, Saussier C, Castot A, Heijbel H, Arnheim-Dahlström L, Sparen P, Mosseveld M, Schuemie M, van der Maas N, Jacobs BC, Leino T, Kilpi T, Storsaeter J, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC. PLoS One. 2014 Jan 3;9(1):e82222. doi: 10.1371/journal.pone.0082222. eCollection 2014.
  18. Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how? Trifirò G, Coloma PM, Rijnbeek PR, Romio S, Mosseveld B, Weibel D, Bonhoeffer J, Schuemie M, van der Lei J, Sturkenboom M. J Intern Med. 2014 Jun;275(6):551-61. doi: 10.1111/joim.12159. Review.
  19. Validation study in four health-care databases: upper gastrointestinal bleeding misclassification affects precision but not magnitude of drug-related upper gastrointestinal bleeding risk. Valkhoff VE, Coloma PM, Masclee GM, Gini R, Innocenti F, Lapi F, Molokhia M, Mosseveld M, Nielsson MS, Schuemie M, Thiessard F, van der Lei J, Sturkenboom MC, Trifirò G; EU-ADR Consortium. J Clin Epidemiol. 2014 Aug;67(8):921-31. doi: 10.1016/j.jclinepi.2014.02.020. Epub 2014 May 1.
  20. Use of oral contraceptives in three European countries: a population-based multi-database study. Bezemer ID, Verhamme KM, Gini R, Mosseveld M, Rijnbeek PR, Trifirò G, Sturkenboom MC, Penning-van Beest FJ, Herings RM. Eur J Contracept Reprod Health Care. 2016;21(1):81-7. doi: 10.3109/13625187.2015.1102220. Epub 2015 Oct 22.
  21. Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study. Coloma PM, de Ridder M, Bezemer I, Herings RM, Gini R, Pecchioli S, Scotti L, Rijnbeek P, Mosseveld M, van der Lei J, Trifirò G, Sturkenboom M; EU-ADR Consortium. Osteoporos Int. 2016 May;27(5):1857-67. doi: 10.1007/s00198-015-3441-2. Epub 2015 Dec 22.
  22. Impact of different assumptions on estimates of childhood diseases obtained from health care data: A retrospective cohort study. Osokogu OU, Pacurariu A, Mosseveld M, Rijnbeek P, Weibel D, Verhamme K, Sturkenboom MCJM. Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):612-620. doi: 10.1002/pds.4413. Epub 2018 Apr 24.
  23. Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease. Alexander M, Loomis AK, Fairburn-Beech J, van der Lei J, Duarte-Salles T, Prieto-Alhambra D, Ansell D, Pasqua A, Lapi F, Rijnbeek P, Mosseveld M, Avillach P, Egger P, Kendrick S, Waterworth DM, Sattar N, Alazawi W. BMC Med. 2018 Aug 13;16(1):130. doi: 10.1186/s12916-018-1103-x.
  24. Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts. Alexander M, Loomis AK, van der Lei J, Duarte-Salles T, Prieto-Alhambra D, Ansell D, Pasqua A, Lapi F, Rijnbeek P, Mosseveld M, Waterworth DM, Kendrick S, Sattar N, Alazawi W. BMC Med. 2019 May 20;17(1):95.
  25. Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults. Alexander M, Loomis AK, van der Lei J, Duarte-Salles T, Prieto-Alhambra D, Ansell D, Pasqua A, Lapi F, Rijnbeek P, Mosseveld M, Avillach P, Egger P, Dhalwani NN, Kendrick S, Celis-Morales C, Waterworth DM, Alazawi W, Sattar N. BMJ. 2019 Oct 8;367:l5367.
  26. Methotrexate and relative risk of dementia amongst patients with rheumatoid arthritis: a multi-national multi-database case-control study. Newby D, Prieto-Alhambra D, Duarte-Salles T, Ansell D, Pedersen L, van der Lei J, Mosseveld M, Rijnbeek P, James G, Alexander M, Egger P, Podhorna J, Stewart R, Perera G, Avillach P, Grosdidier S, Lovestone S, Nevado-Holgado AJ. Alzheimers Res Ther. 2020 Apr 6;12(1):38.
  27. Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. Lane JCE, Weaver J, Kostka K, Duarte-Salles T, Abrahao MTF, Alghoul H, Alser O, Alshammari TM, Biedermann P, Banda JM, Burn E, Casajust P, Conover MM, Culhane AC, Davydov A, DuVall SL, Dymshyts D, Fernandez-Bertolin S, Fišter K, Hardin J, Hester L, Hripcsak G, Kaas-Hansen BS, Kent S, Khosla S, Kolovos S, Lambert CG, van der Lei J, Lynch KE, Makadia R, Margulis AV, Matheny ME, Mehta P, Morales DR, Morgan-Stewart H, Mosseveld M, Newby D, Nyberg F, Ostropolets A, Park RW, Prats-Uribe A, Rao GA, Reich C, Reps J, Rijnbeek P, Sathappan SMK, Schuemie M, Seager S, Sena AG, Shoaibi A, Spotnitz M, Suchard MA, Torre CO, Vizcaya D, Wen H, de Wilde M, Xie J, You SC, Zhang L, Zhuk O, Ryan P, Prieto-Alhambra D; OHDSI-COVID-19 consortium. Lancet Rheumatol. 2020 Nov;2(11):e698-e711.
  28. Prevalence and incidence rate of hospital admissions related to medication between 2008 and 2013 in The Netherlands. Lghoul-Oulad Saïd F, Hek K, Flinterman LE, Herings RM, Warlé-van Herwaarden MF, de Bie S, Valkhoff VE, Alsma J, Mosseveld M, Vanrolleghem AM, Stricker BH, Sturkenboom MC, De Smet PA, van den Bemt PM. Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1659-1668.
  29. Treatment pathway analysis of newly diagnosed dementia patients in four electronic health record databases in Europe. James G, Collin E, Lawrance M, Mueller A, Podhorna J, Zaremba-Pechmann L, Rijnbeek P, van der Lei J, Avillach P, Pedersen L, Ansell D, Pasqua A, Mosseveld M, Grosdidier S, Gungabissoon U, Egger P, Stewart R, Celis-Morales C, Alexander M, Novak G, Gordon MF. Soc Psychiatry Psychiatr Epidemiol. 2021 Mar;56(3):409-416.
  30. Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study. Lane JCE, Weaver J, Kostka K, Duarte-Salles T, Abrahao MTF, Alghoul H, Alser O, Alshammari TM, Areia C, Biedermann P, Banda JM, Burn E, Casajust P, Fister K, Hardin J, Hester L, Hripcsak G, Kaas-Hansen BS, Khosla S, Kolovos S, Lynch KE, Makadia R, Mehta PP, Morales DR, Morgan-Stewart H, Mosseveld M, Newby D, Nyberg F, Ostropolets A, Woong Park R, Prats-Uribe A, Rao GA, Reich C, Rijnbeek P, Sena AG, Shoaibi A, Spotnitz M, Subbian V, Suchard MA, Vizcaya D, Wen H, Wilde M, Xie J, You SC, Zhang L, Lovestone S, Ryan P, Prieto-Alhambra D; OHDSI-COVID-19 consortium. Rheumatology (Oxford). 2021 Jul 1;60(7):3222-3234.
  31. Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US. Li X, Burn E, Duarte-Salles T, Yin C, Reich C, Delmestri A, Verhamme K, Rijnbeek P, Suchard MA, Li K, Mosseveld M, John LH, Mayer MA, Ramirez-Anguita JM, Cohet C, Strauss V, Prieto-Alhambra D. BMJ. 2022 Oct 26;379:e071594.
  32. Data Resource Profile: The Integrated Primary Care Information (IPCI) database, The Netherlands. de Ridder MAJ, de Wilde M, de Ben C, Leyba AR, Mosseveld BMT, Verhamme KMC, van der Lei J, Rijnbeek PR. Int J Epidemiol. 2022 Dec 13;51(6):e314-e323.
  33. Drug utilization analysis of osteoporosis medications in seven European electronic health databases. Tan EH, Robinson DE, Jödicke AM, Mosseveld M, Bødkergaard K, Reyes C, Moayyeri A, Voss A, Marconi E, Lapi F, Reinold J, Verhamme KMC, Pedersen L, Braitmaier M, de Wilde M, Ruiz MF, Aragón M, Bosco-Levy P, Lassalle R, Prieto-Alhambra D, Sanchez-Santos MT. Osteoporos Int. 2023 Jul 12.